EZH2 modulates T cell activation in liver cancer
In an era where personalized medicine is rapidly evolving, understanding the cellular underpinnings of diseases such as hepatocellular carcinoma (HCC) ...
In an era where personalized medicine is rapidly evolving, understanding the cellular underpinnings of diseases such as hepatocellular carcinoma (HCC) ...
The enzyme SETD2 has recently emerged as a critical regulator of immune cell biology, offering promising avenues for therapeutic intervention ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine